These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32426360)

  • 1. Autoinflammatory Mechanisms in Crystal-Induced Arthritis.
    Oliviero F; Bindoli S; Scanu A; Feist E; Doria A; Galozzi P; Sfriso P
    Front Med (Lausanne); 2020; 7():166. PubMed ID: 32426360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dermatologic perspective on autoinflammatory diseases.
    Marzano AV; Damiani G; Genovese G; Gattorno M
    Clin Exp Rheumatol; 2018; 36 Suppl 110(1):32-38. PubMed ID: 29742056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and Clinical Examination of Autoinflammatory Syndrome].
    Ida H
    Rinsho Byori; 2015 May; 63(5):598-604. PubMed ID: 26524899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis and Clinical Examination of Autoinflammatory Syndrome].
    Ida H
    Rinsho Byori; 2015 Oct; 63(10):1207-12. PubMed ID: 26897858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interactions Between Autoinflammation and Type 2 Immunity: From Mechanistic Studies to Epidemiologic Associations.
    Sylvester M; Son A; Schwartz DM
    Front Immunol; 2022; 13():818039. PubMed ID: 35281022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade.
    DeSena AD; Do T; Schulert GS
    J Neuroinflammation; 2018 Feb; 15(1):38. PubMed ID: 29426321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β.
    Kim ML; Chae JJ; Park YH; De Nardo D; Stirzaker RA; Ko HJ; Tye H; Cengia L; DiRago L; Metcalf D; Roberts AW; Kastner DL; Lew AM; Lyras D; Kile BT; Croker BA; Masters SL
    J Exp Med; 2015 Jun; 212(6):927-38. PubMed ID: 26008898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.
    Federici S; Martini A; Gattorno M
    Front Immunol; 2013 Oct; 4():351. PubMed ID: 24198817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.
    Manthiram K; Zhou Q; Aksentijevich I; Kastner DL
    Nat Immunol; 2017 Jul; 18(8):832-842. PubMed ID: 28722725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives.
    Savic S; Dickie LJ; Wittmann M; McDermott MF
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):505-33. PubMed ID: 23040364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perception of self: distinguishing autoimmunity from autoinflammation.
    van Kempen TS; Wenink MH; Leijten EF; Radstake TR; Boes M
    Nat Rev Rheumatol; 2015 Aug; 11(8):483-92. PubMed ID: 25963881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric hereditary autoinflammatory syndromes.
    Jesus AA; Oliveira JB; Hilário MO; Terreri MT; Fujihira E; Watase M; Carneiro-Sampaio M; Silva CA
    J Pediatr (Rio J); 2010; 86(5):353-66. PubMed ID: 20938587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment.
    Havnaer A; Han G
    Am J Clin Dermatol; 2019 Aug; 20(4):539-564. PubMed ID: 30997665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.
    Satoh T; Otsuka A; Contassot E; French LE
    Immunotherapy; 2015; 7(3):243-54. PubMed ID: 25804477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monogenic Auto-inflammatory Syndromes: A Review of the Literature.
    Azizi G; Khadem Azarian S; Nazeri S; Mosayebian A; Ghiasy S; Sadri G; Mohebi A; Khan Nazer NH; Afraei S; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2016 Dec; 15(6):430-444. PubMed ID: 28129677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Brief History of IL-1 and IL-1 Ra in Rheumatology.
    Dayer JM; Oliviero F; Punzi L
    Front Pharmacol; 2017; 8():293. PubMed ID: 28588495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and Epigenetic Determinants in Autoinflammatory Diseases.
    Álvarez-Errico D; Vento-Tormo R; Ballestar E
    Front Immunol; 2017; 8():318. PubMed ID: 28382039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoinflammatory diseases].
    Russo RA; Katsicas MM
    Medicina (B Aires); 2016; 76(3):166-72. PubMed ID: 27295706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare hereditary autoinflammatory disorders: towards an understanding of critical in vivo inflammatory pathways.
    Kanazawa N
    J Dermatol Sci; 2012 Jun; 66(3):183-9. PubMed ID: 22336993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.